The Technical Analyst
Select Language :
Exact Sciences Corp [EXAS]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research

Exact Sciences Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Exact Sciences Corp is listed at the  Exchange

3.26% $69.06

America/New_York / 28 mar 2024 @ 16:00


Exact Sciences Corp: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 12 537 mill
EPS: -1.130
P/E: -61.12
Earnings Date: May 07, 2024
SharesOutstanding: 181.53 mill
Avg Daily Volume: 1.958 mill
RATING 2024-03-28
A
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Neutral
Return On Asset: Buy
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -61.12 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-3.27x
Company: PE -61.12 | industry: PE 18.71
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 66.24 - 71.89

( +/- 4.09%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-29 Orville Jacob A Buy 4 724 Common Stock
2024-03-01 Orville Jacob A Sell 2 154 Common Stock
2024-02-29 Orville Jacob A Sell 4 724 Restricted Stock Units
2024-03-01 Levangie Daniel J Sell 5 000 Common Stock
2024-02-29 Herriott James Buy 1 890 Common Stock
INSIDER POWER
37.39
Last 100 transactions
Buy: 546 749 | Sell: 248 946

Forecast: 16:00 - $69.16

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $69.16
Forecast 2: 16:00 - $69.16
Forecast 3: 16:00 - $69.16
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $69.06 (3.26% )
Volume 5.38 mill
Avg. Vol. 1.958 mill
% of Avg. Vol 274.93 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Exact Sciences Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Exact Sciences Corp

RSI

Intraday RSI14 chart for Exact Sciences Corp

Last 10 Buy & Sell Signals For EXAS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$60.93N/AActive
Profile picture for
            Exact Sciences Corp

EXAS

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Last 10 Buy Signals

Date Signal @
WBTUSDMar 29 - 07:408.44
TETUSDMar 29 - 07:3827.93
KUJIUSDMar 29 - 07:392.56
MKRUSDMar 29 - 07:36$3 525.33
LEOUSDMar 29 - 07:346.06
YFIIUSDMar 29 - 07:30$609.96
PAXGUSDMar 29 - 07:302 210.17
XAUTUSDMar 29 - 07:19$2 232.78
POLYXUSDMar 29 - 07:190.529
VRXUSDMar 29 - 07:1862.71

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.